Evidence mapPaperPMID 40546754Full record

ReviewInternational journal of cardiology. Congenital heart disease2025

The PAH patient's perspective.

Daniel A Jeffery, Wendy Gin-Sing, Radwa Bedair, Luke S Howard

Abstract readReview
In one paragraph

Review in International journal of cardiology. Congenital heart disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Advancing the science and care of pulmonary hypertension, globally.International journal of cardiology. Congenital heart disease · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel A JefferyMorriston Cardiac Centre, Swansea Bay University Healthboard, Swansea, SA6 6NL, UK.
Wendy Gin-SingNational Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College Healthcare Trust, London, W12 0HS, UK.
Radwa BedairBristol Heart Institute, Bristol Royal Infirmary, Bristol, BS2 8HW, UK.
Luke S HowardNational Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College Healthcare Trust, London, W12 0HS, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary Hypertension is a serious condition which can occur in adults living with congenital heart disease. Due to advances in the care of patients with congenital heart disease, patients are living longer with the condition. Unfortunately, patients living with Pulmonary Arterial Hypertension associated with Congenital Heart Disease (PAH-CHD) face a number of different issues directly related to their condition, which range from physical limitations and uncertainty over their diagnosis, which in some cases cause significant depression and anxiety, to impact on their relationships with friends and family, financial challenges and family planning. In this article, we interview two patients living with PAH-CHD and discuss the numerous issues that patients may face as a direct result of their condition.

Indexed as

Adult congenital heart diseasePulmonary arterial hypertensionQuality of life

Identifiers

PMID40546754
PMCPMC12178787

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.